Covestor’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
Covestor's NVCR Position: Q3 2026 in Review
Covestor reduced its NovoCure (NVCR) stake by 1.6% in Q3 2026, selling an estimated $134 and leaving 485 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #1662.
Covestor first reported a position in NVCR in Q4 2021 and has held it in 20 quarters since. The position peaked at $19K in Q4 2024. 242 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.
- Covestor held 485 shares of NovoCure worth $8K as of Q3 2026.
- Covestor sold 8 NovoCure shares in Q3 2026, an estimated $134.
- NovoCure made up 0.01% of Covestor's portfolio in Q3 2026, its #1662 holding.
- Covestor first reported a position in NovoCure in Q4 2021 and has held it in 20 quarters since.
- Covestor's NovoCure position peaked at $19K in Q4 2024.
- 242 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.